Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Jul;32(4):418-427.
doi: 10.1136/tobaccocontrol-2021-056819. Epub 2021 Oct 19.

IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation

Affiliations

IQOS marketing strategies in the USA before and after US FDA modified risk tobacco product authorisation

Carla J Berg et al. Tob Control. 2023 Jul.

Abstract

Introduction: Given that the US Food and Drug Administration (FDA) authorised reduced exposure messaging to be used in IQOS marketing, we examined: (1) IQOS ad content; (2) advertising media channels and (3) changes in advertising efforts over time.

Methods: We conducted a mixed-methods study regarding IQOS ad content (headlines, themes, images), ad occurrence characteristics (including content, media channels and adspend) in the USA from August 2019 to April 2021 using Numerator advertising/marketing data.

Results: Across 24 unique ads and 591 occurrences (84.6% online, 8.0% print, 7.4% mobile), there was $4 902 110 total adspend (98.9% allocated to print). Across unique ads, occurrences and adspend, prominent themes included 'real tobacco' (45.8%, 47.4%, 30.1%, respectively), less odour/ash (29.2%, 21.0%, 29.9%) and switching from cigarettes (25.0%, 19.5%, 69.4%), and images mainly featured the product alone (58.2%, 61.4%, 99.5%) or with women (25.0%, 19.1%, 0.3%). Per occurrences and adspend, the most prominent media channel themes (eg, magazine/website topics) were technology (19.3%, 10.6%), women's fashion (18.1%, 26.2%), weather/news (9.0%, 15.3%) and entertainment/pop culture/gaming (8.5%, 23.1%). Ad themes appearing only post-FDA authorisation included switching from traditional cigarettes, same-day/home-delivery, convenience (eg, use indoors), reduced exposure to some dangerous substances, science/research and distinction from e-cigarettes. Overall adspend per occurrence increased postauthorisation (p=0.016); the highest adspend per unique ad (69.3% of total) focused on ads featuring reduced exposure.

Conclusions: Regulatory efforts must be informed by ongoing surveillance of IQOS marketing efforts and its impacts, particularly how specific consumer subgroups (eg, tobacco non-users, women, young people) are impacted by marketing exposure.

Keywords: advertising and promotion; non-cigarette tobacco products; packaging and labelling; public policy; tobacco industry.

PubMed Disclaimer

Conflict of interest statement

Competing interests: YB-Z has received fees for lectures from Pfizer Ltd, Novartis NCH and GSK Consumer Health (distributors of smoking cessation pharmacotherapy in Israel) in the past (2012 to July 2019). HL had received fees for lectures from Pfizer Israel Ltd (distributor of a smoking cessation pharmacotherapy in Israel) in 2017. LA receives royalties for the sale of Text2Quit and is a shareholder in Welltok, Inc.

Figures

Figure 1.
Figure 1.
Advertising characteristics across media channels and time Note: Ad occurrences defined as ad campaigns, which could use: [a] existing or recut ad content or unique ad content and [b] similar or distinct channels and markets. Digital impressions defined as digital views or engagements with the ads as derived by Web-indexing technology, audience measurement data from comScore, and estimated cost per thousand impressions for each monitored site.

References

    1. Robertson L, Cameron C, McGee R, Marsh L, Hoek J. Point-of-sale tobacco promotion and youth smoking: a meta-analysis. Tob Control. 2016;25(e2):e83–e89. - PubMed
    1. St.Helen G, Jacob Iii P, Nardone N, Benowitz NL. IQOS: examination of Philip Morris International’s claim of reduced exposure. Tob Control. 2018;27(Suppl 1):s30. - PMC - PubMed
    1. Nyman AL, Weaver SR, Popova L, et al. Awareness and use of heated tobacco products among US adults, 2016–2017. Tob Control. 2018;27(Suppl 1):s55–s61. - PMC - PubMed
    1. Sutanto E, Miller C, Smith DM, et al. Prevalence, Use Behaviors, and Preferences among Users of Heated Tobacco Products: Findings from the 2018 ITC Japan Survey. Int J Environ Res Public Health. 2019;16(23). - PMC - PubMed
    1. Liu X, Lugo A, Spizzichino L, Tabuchi T, Pacifici R, Gallus S. Heat-not-burn tobacco products: concerns from the Italian experience. Tobacco Control. 2019;28(1):113. - PubMed

Publication types